Earnings Presentation - 3Q14
Earnings Presentation - 3Q14
Earnings Presentation - 3Q14
3Q14 Highlights
Solid results in a challenging environment; one-off charge
FINANCIAL HIGHLIGHTS (3Q14 vs. 3Q13)
Excludes stock options plan cost, depreciation, tax on dividends from CME Group and provisions. 2 According to CVM Rule 527/12 that does not exclude equity method accounting.
Excludes deferred liability recognized in correlation with temporary differences from amortization of goodwill for tax purposes, stock options plan cost, investment in associate (CME
Group) accounted under the equity method of accounting, net of taxes related to dividends and taxes paid overseas to be compensated.
3Q14
5.061
13.115
13.145
12.999
5.502
MINI CONTRACTS
(in R$)
11.3%
9.1%
215.1
202.8
3Q13
4Q13
8.8%
249.4
255.1
1Q14
2Q14
FX rate (R$/US$) in the quarter, considering the closing price for previous month.
11.9%
316.8
3Q14
% Total
DERIVATIVES REVENUE
(BM&F + BOVESPA) ACCOUNTED FOR
43.5% OF THE TOTAL
38.1%: Cash Market
5.9%: Trading
32.2%: Post-Trade
5.7%: Stock and Indices Derivatives
37.8%: Financial/Commodity Derivatives
Total Revenue
R$594.7 million
1Trading
and Post-trade
*Include expenses with maintenance in general, taxes adjusted by the dividends from CME Group, board and committee members compensation and others.
Third party
Marketing Communicat.
services
Data
processing
Personnel
expenditure
(in R$ millions)
9M13
-2.2%
Diligent management of
assets and headcount
dimensioning; lower profit
sharing
3.5%
-3.0%
Review of contracts,
legacy system deprecated
2.9%
-3.6%
Inflationary contract
adjustments
Contracts review
260.6
226.5
9M14
264.2
237.5
9M13
81.3
9M14
84.2
9M13
25.7
4.9%
26.5
9M14
-22.8%
-27.6%
Inflationary contract
adjustments
Improvements and
eletctronification of the
mailing process for
statements successfully
implemented
-18.0%
-23.2%
Inflationary contract
adjustments
Strategic review of
marketing activities;
ongoing process of
expenses review
13.2
9M13
9M14
10.2
9M13
9.9
9M14
Real Var.
Nominal Var.
8.1
Includes personnel capitalization and excludes stock option and bonus expenses, Calculated based on the annual wage increase between 2013 and 2014 for personnel expenditure and
the IPCA of services accumulated from September, 2013 to September, 2014 for the other expenses lines.
Financial Highlights
Consistently returning capital to shareholders
CASH AND FINANCIAL INVESTMENTS
(In R$ millions)
Payout
3Q14
2Q14
1,390
360
1,131
404
1,037
909
3,842
1,055
3,497
1,053
Share Buyback
1Q14
4Q13
3Q13
2,441
2,134
1,686
432
457 359
497 355
897
1,307
1,921
1,960
5,077
4,871
4,498
FINANCIAL RESULT
Financial result of R$47.3 MM, down 4.6% from 3Q13,
explained mainly by R$18.1 MM interest payment in
connection with the settlement of a tax dispute under the
REFIS
CAPEX
Clearinghouses required safeguards: growth in line
with additional collateral pledged by market
participants
BM&FBOVESPA Clearinghouse
Phase 1: financial and commodity derivatives market
On August 18, post-trade for financial and
commodities derivatives successfully migrated
to the new integrated clearinghouse, benefiting
investors in these markets with the capital
efficiency brought by CORE
Capital Efficiency
R$20 billion in collaterals was released
R$15 billion reduction in required collateral
R$5 billion increased value of collaterals
2015
2016
Phase 1 (derivatives)
Deployment of the new
Clearinghouse in the
derivatives market
Phase 2 (equities)
IT development and
beginning of testing
Phase 2 (equities)
Certification, parallel
production and go live
(4Q16)*
*Implementation subject to the results of the tests with the market and the authorization of the regulators.
10
Resilient IT Infrastructure
Capacity and resilience of the system tested in times of high volatility
Oct-27-14
Record # of Trades
2,582,718
Oct-16-14
Record # of Trades
376,741
200
1
0
Jan-14 Feb-14Mar-14 Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14
100
0
Jan-14 Feb-14Mar-14 Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14
11
APPENDIX
12
Growth Products
Increasing revenue diversification
REVENUE GROWTH OF SELECTED PRODUCTS
Securities Lending
Tesouro Direto
Market maker for options on single stocks
Exchange traded funds (ETF)
Agribusiness credit bills (LCA)
Real estate investment funds (FII)
Non sponsored Brazilian Depositary Receipts (BDRs N1 NP)
CAGR
(2010-14):
+22.9%
(In R$ millions)
13
Financial Statements
Summary of Balance Sheet (Consolidated)
ASSETS
9/30/2014
12/31/2013
(in R$ millions)
3,025.6
4,319.5
370.0
1,196.6
2,337.0
2,853.4
Others
318.5
269.5
22,214.7
21,577.2
1,517.3
1,135.4
1,134.2
820.8
383.1
314.6
3,544.6
3,346.3
421.0
423.2
16,731.7
16,672.3
Others
Goodwill
16,064.3
16,064.3
Minority shareholdings
Total Assets
25,240.3
Current assets
Cash and cash equivalents
Financial investments
Others
Non-current assets
Long-term receivables
Financial investments
Others
Investments
Property and equipment
Intangible assets
9/30/2014
12/31/2013
1,888.7
2,710.8
1,333.4
2,073.0
555.3
637.9
Non-current liabilities
4,386.1
3,886.9
1,493.2
1,426.2
2,718.7
2,295.8
174.2
165.0
18,965.4
19,298.9
2,540.2
2,540.2
15,213.7
16,056.7
1,196.4
687.3
15.1
14.7
25,240.3
25,896.7
Current liabilities
Others
Shareholders equity
Capital stock
Capital reserve
14
Financial Statements
Net income and adjusted expenses reconciliations
ADJUSTED NET INCOME RECONCILIATION
3Q14
3Q13
238.4 281.6
7.3
5.6
138.6 138.9
(43.7) (38.2)
16.7
15.8
357.4 403.7
Net Income*
Stock options plan
Deferred tax liabilities
Equity in income of investees (net of taxes)
Recoverable taxes paid overseas
Adjusted Net Income
Change
3Q14/3Q13
-15.3%
30.2%
-0.2%
14.3%
5.6%
-11.5%
2Q14
250.1
7.6
138.6
(39.8)
16.3
372.8
Change
3Q14/2Q14
-4.7%
-3.2%
0.0%
9.9%
2.5%
-4.1%
9M14
9M13
744.6
21.8
415.9
(128.1)
51.2
1,105.4
899.4
21.4
416.7
(117.0)
47.4
1,267.9
Change
9M14/9M13
-17.2%
2.0%
-0.2%
9.4%
7.9%
-12.8%
193.8
(29.5)
(7.3)
(5.8)
(4.3)
146.8
3Q13
194.1
(32.5)
(5.6)
(5.1)
(0.6)
150.2
Change
3Q14/3Q13
-0.2%
-9.2%
30.2%
13.2%
-2.3%
2Q14
178.2
(28.0)
(7.6)
(5.3)
(3.2)
134.1
Change
3Q14/2Q14
8.7%
5.2%
-3.2%
9.2%
36.7%
9.5%
9M14
558.3
(87.1)
(21.8)
(16.6)
(15.4)
417.4
9M13
543.7
(88.4)
(21.4)
(14.8)
(11.8)
407.3
Change
9M14/9M13
2.7%
-1.5%
2.0%
12.1%
30.4%
2.5%
15
(in R$ millions)
Net revenues
3Q14
3Q13
Change
Change
2Q14
9M14
3Q14/3Q13
3Q14/2Q14
546.0
535.4
(193.8)
(194.1)
352.2
341.3
64.5%
63.7%
47.3
49.6
-4.6%
59.5
Financial result
449.0
434.2
3.4%
Net income*
238.4
281.6
357.4
Expenses
Operating income
Operating margin
Equity in income of investees
2.0%
464.8
-0.2% (178.2)
3.2%
9M13
(558.3)
Change
9M14/9M13
-9.4%
(543.7)
2.7%
942.1 1,112.5
-15.3%
286.6
22.9%
76 bps 61.7%
286 bps
62.8%
67.2%
-438 bps
-20.5%
154.9
129.8
19.3%
391.1
-9.6%
-15.3%
250.1
-4.7%
899.4
-17.2%
403.7
-11.5%
372.8
-12.8%
0.195
0.211
-7.5%
0.203
-3.8%
0.601
0.660
-9.0%
(146.8)
(150.2)
-2.3% (134.1)
9.5%
(417.4)
(407.3)
2.5%
744.6
16
www.bmfbovespa.com.br/ir